5 Tech Stocks To Sell Now According to Cathie Wood

2. Editas Medicine, Inc. (NASDAQ:EDIT)

Number of Hedge Fund Holders: 21

Massachusetts-based Editas Medicine, Inc. (NASDAQ:EDIT) ranks second in our list of the tech stocks that were sold by Cathie Wood during the fourth quarter of 2022. It’s a clinical-stage biotech company that is developing therapies for rare diseases based on CRISPR gene editing technology. Cathie Wood’s ARK had over 145,000 shares of Editas Medicine, Inc. (NASDAQ:EDIT) as of the end of the third quarter of 2022. These shares were sold by the hedge fund during the fourth quarter of 2022.

Earlier this month, investment firm Cantor Fitzgerald gave an Overweight rating to Editas Medicine (NASDAQ:EDIT) as the firm’s analyst Rick Bienkowski gave bullish comments for gene editing companies. The analyst has a $15 price target for Editas Medicine, Inc. (NASDAQ:EDIT). He said that Editas Medicine, Inc. (NASDAQ:EDIT) is positioned well to appreciate in the coming year amid favorable intellectual property positioning and expected clinical data updates.